Formulation and Evaluation of Salbutamol Sulphate Taste Masked Oral Disintegrating Tablets
DOI:
https://doi.org/10.37285/ijpsn.2021.14.4.7Abstract
Salbutamol is a short acting, selective beta2-adrenergic receptor agonist used in the treatment of astama and COPD. The aim of this study is to formulate oral disintegrating tablets of salbutamol sulphate to achieve rapid dissolution, absorption and further improving the bioavailability of the drug. Oral disintegrating tablets of salbutamol sulphate were designed with a view to enhance the patient compliance and provide a quick onset of action. The oral disintegrating tablets were prepared by using different synthetic polymers by direct compression method. Development of the formulation in the present study was based on the concentration of superdisintegrants and the properties of the drug. Nine batches of tablets were formulated and evaluated for various parameters: drug content, weight variation, water absorption ratio, wetting time, in vitro disintegration, hardness, friability, thickness uniformity, and in vitro dissolution. A fourier-transform infrared spectroscopy (FTIR) study showed that there were no significant interactions between the drug and the excipients. The prepared tablets were good in appearance and showed acceptable results for hardness and friability. The in vitro disintegrating time of the formulated tablets was found to be 14.39-32.41 sec and the drug content of tablets in all formulations was found to be between 87.48-99.96 %, which complied within the limits established in the Indian pharmacopeia. The study concluded that taste of the drug was masked with the help of sodium saccarhin, flavor and the concentration of super disintegrating agent increases the disintegration time of tablets get decreases. The formulation (F9) had a minimum disintegration time of 14.39 sec and 99.96 % of the drug was released within 20 min.
Downloads
Metrics
Keywords:
Direct compression, salbutamol sulfate, crosspovidone, crosscaramellose sodium, sodium starch glycolate, super disintegrant
Downloads
Published
How to Cite
Issue
Section
References
Abay FB and Ugurlu T (2015). Orally disintegrating tablets: a short review. Journal of Pharmaceutics & Drug Development: 3(3): 303.
Agiba AM and Eldin AB (2019). Insights into formulation technologies and novel strategies for the design of orally disintegrating dosage forms: A comprehensive industrial review. Int. J. Pharm. Pharm. Sci: 11: 8-20.
Aher S, Saudagar R and Chaudhari D (2018). Formulation and evaluation of taste masked fast dissolving tablet of prazosin hydrochloride. Journal of Drug Delivery and Therapeutics: 8(4): 263-71.
Al-khattawi A and Mohammed AR (2013). Compressed orally disintegrating tablets: excipients evolution and formulation strategies. Expert opinion on drug delivery: 10(5): 651-63.
Amperiadou, A., and Georgarakis, M (1995). Controlled release salbutamol sulphate microcapsules prepared by emulsion solvent-evaporation technique and study on the release affected parameters. International Journal of Pharmaceutics: 115(1): 1-8.
Bandari S, Mittapalli RK and Gannu R (2014). Orodispersible tablets: An overview. Asian Journal of Pharmaceutics: 26: 2(1).
Chinnala KM and Vodithala S (2017). Formulation development and evaluation of fast disintegrating tablets of cinitapride hydrogen tartarate by using direct compression technique. Int J Curr Pharm Res: 9(6): 98-103.
Gowthami R, Sujitha H, Rajashekar TN, Krishna KM, Kumar YS and Rao YM (2013). Formulation and Evaluation of Sumatriptan Succinate Fast Disintegrating Films and Tablets. International Journal of Pharmaceutical Sciences and Nanotechnology: 6(2): 2081-2096.
Hannan PA, Khan JA, Khan A and Safiullah S (2016). Oral dispersible system: A new approach in drug delivery system. Indian Journal of Pharmaceutical Sciences: 78(1): 2.
Heer D, Aggarwal G and Kumar SH (2013). Recent trends of fast dissolving drug delivery system–an overview of formulation technology. Pharmacophor: 4(1): 1-9.
Hirani JJ, Rathod DA and Vadalia KR (2009). Orally disintegrating tablets: a review. Tropical Journal of Pharmaceutical Research: 8(2): 161-172.
Kannuri R, Challa T and Chamarthi H (2011). Taste masking and evaluation methods for orodispersible tablets. Int Jour Pharm Ind Res: 1(3): 201-10.
Markl D and Zeitler JA (2017). A review of disintegration mechanisms and measurement techniques. Pharmaceutical research: 34(5): 890-917.
Mohalkar R, Poul B, Patil SS, Shetkar MA and Chavan D (2014). A review on immediate release drug delivery systems. Pharma Tutor: 2(8): 95-109.
Mogili RK, Kannaiah J, Rao PM and Lakshman P (2014). Formulation and evaluation of Metformin Immidiate Release Tablet. Indo American Journal of Pharmaceutical Sciences: 1(4): 209-18.
Pallothu SC, Sandeepthi N and Sriram N (2018). Fabrication and Optimization of Various Superdisintegrants to Formulate Zolpidem Tartarate Fast Dissolving Tablets. Int. J. of Pharmacy and Analytical Research: 7(1): 81-95.
Pande V, Karale P, Goje P and Mahanavar S (2016). An overview on emerging trends in immediate release tablet technologies. Austin Therapeutics: 3(1): 1026.
Pandey P and Dahiya M (2016). Oral disintegrating tablets: a review. International Journal of Pharma Research & Review: 5(1): 50-62.
Parkash V, Maan S, Deepika SK and Hemlata VJ (2011). Fast disintegrating tablets: Opportunity in drug delivery system. Journal of Advanced Pharmaceutical Technology & Research: 2(4): 223.
Prabhu P, Dubey A and Kamath K (2015). Formulation and evaluation of fast-dissolving films of lisinopril. Egyptian Pharmaceutical Journal: 14(1): 56.
Prasad VB, Rao GK, Rani BR, Kumar BR, Sudhakar B, Devi PU and Murthy KV (2012). In-vitro and in-vivo evaluation tests for floating drug delivery systems: a review. International Journal of Pharmacy: 2: 645-55.
Ragade SM, Jain AA and Barhate S (2017). A Review on Mouth dissolving drug delivery system. World J Pharm Pharm Sci: 6(10): 467-480.
Samvedna S, Jindal S, Mishra G, Madan JR, Gupta G, Awasthi R, Pinto TD, Dua K and Kulkarni GT (2018). Formulation and characterization of oral rapid disintegrating tablets of levocetirizine. Polim Med: 48(1): 31-40.
Shariff ZB, Dahmash DT, Kirby DJ, Missaghi S, Rajabi-Siahboomi A and Maidment ID (2020). Does the Formulation of Oral Solid Dosage Forms Affect Acceptance and Adherence in Older Patients? A Mixed Methods Systematic Review. Journal of the American Medical Directors Association.
Sharma KS, Sharma R and Sagar GV (2010). Fast Dissolving Tablets-A Review and Recent Advances in Manufacturing Technologies. Research Journal of Pharmaceutical Dosage Forms and Technology: 2(2): 120-4.
Shireesha G, Harika S and Shravan Kumar Y (2019). Formulation and Evaluation of Metoprolol Tartrate Sustained Release Matrix Tablets. International Journal of Pharmaceutical Sciences and Nanotechnology: 12(5): 4665-71.
Shishu K and Kapoor VR (2010). Development of taste masked oral formulation of ornidazole. Indian Journal of Pharmaceutical Sciences: 72(2): 211.
Sohi H, Sultana Y and Khar RK (2004). Taste masking technologies in oral pharmaceuticals: recent developments and approaches. Drug Development and Industrial Pharmacy: 30(5): 429-48.
Talevi A and Quiroga PA (2018). ADME Processes in Pharmaceutical Sciences: Dosage, Design, and Pharmacotherapy Success. Springer.
Venkateswarlu KA, Thirumalesh Naik SB and Chandrasekhar KB (2016). Formulation and in vitro evaluation of orlistat orodispersible tablets for enhancement of dissolution rate. Int. J. Pharm.Sci: 8(4): 236-41.
Thoke SB, Gayke A, Dengale R, Patil P and Sharma Y (2012). Review on: taste masking approaches and evaluation of taste masking. Int J Pharm Sci: 4(2): 1895-907.
Yadav G, Kapoor A and Bhargava S (2012). Fast dissolving tablets recent advantages: A review. International Journal of Pharmaceutical Sciences and Research: 3(3): 728.
